{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:44:03Z","timestamp":1791233043586,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"CGI"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jid.2017.03.039","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T17:45:17Z","timestamp":1494956717000},"page":"1955-1964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["MiR-200a Regulates CDK4\/6 Inhibitor Effect by Targeting CDK6 in Metastatic\u00a0Melanoma"],"prefix":"10.1016","volume":"137","author":[{"given":"Matias A.","family":"Bustos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeshi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego M.","family":"Marzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nellie","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave S.B.","family":"Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.03.039_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/nar\/gkv1221","article-title":"Bioinformatic tools for microRNA dissection","volume":"44","author":"Akhtar","year":"2016","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/j.jid.2017.03.039_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat Rev Drug Disc"},{"issue":"9","key":"10.1016\/j.jid.2017.03.039_bib3","doi-asserted-by":"crossref","first-page":"e75517","DOI":"10.1371\/journal.pone.0075517","article-title":"Identification of an enhancer that increases miR-200b\u223c200a\u223c429 gene expression in breast cancer cells","volume":"8","author":"Attema","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jid.2017.03.039_bib4","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1158\/1078-0432.CCR-15-1185","article-title":"FDA approval: palbociclib for the treatment of postmenopausal patients with estrogen receptor-positive, HER2-negative metastatic breast cancer","volume":"21","author":"Beaver","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2017.03.039_bib5","doi-asserted-by":"crossref","first-page":"7846","DOI":"10.1158\/0008-5472.CAN-08-1942","article-title":"A\u00a0double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition","volume":"68","author":"Bracken","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2017.03.039_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/CMR.0b013e328361926c","article-title":"Melanoma-related mortality and productivity losses in the USA, 1990-2008","volume":"23","author":"Bristow","year":"2013","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2017.03.039_bib7","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1158\/1541-7786.MCR-10-0052","article-title":"Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer","volume":"8","author":"Ceppi","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jid.2017.03.039_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(15)00613-0","volume":"17","author":"Cristofanilli","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2017.03.039_bib9","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/onc.2011.383","article-title":"Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis","volume":"31","author":"Davalos","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2017.03.039_bib10","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/sj.onc.1209651","article-title":"Retinoblastoma family genes","volume":"25","author":"Du","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2017.03.039_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(14)71159-3","article-title":"The cyclin-dependent kinase 4\/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1\/TRIO-18): a randomised phase 2 study","volume":"16","author":"Finn","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2017.03.039_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jid.2017.03.039_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ctrv.2016.03.002","article-title":"Targeting CDK4\/6 in patients with cancer","volume":"45","author":"Hamilton","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jid.2017.03.039_bib14","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.18632\/oncotarget.3052","article-title":"The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy","volume":"6","author":"Humphries","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.jid.2017.03.039_bib15","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2017.03.039_bib16","doi-asserted-by":"crossref","first-page":"11121","DOI":"10.1073\/pnas.1300873110","article-title":"Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis","volume":"110","author":"Lee","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2017.03.039_bib17","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/jid.2015.200","article-title":"The CASC15 long intergenic noncoding RNA locus is involved in melanoma progression and phenotype switching","volume":"135","author":"Lessard","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.03.039_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jid.2017.03.039_bib19","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1242\/jcs.122275","article-title":"Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state","volume":"126","author":"Lim","year":"2013","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jid.2017.03.039_bib20","first-page":"332","article-title":"Role of microRNAs in chemoresistance","volume":"3","author":"Magee","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jid.2017.03.039_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/pcmr.12307","article-title":"Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome","volume":"28","author":"Marzese","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2017.03.039_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/hmg\/ddt420","article-title":"Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis","volume":"23","author":"Marzese","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2017.03.039_bib23","first-page":"1499","article-title":"DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations","volume":"16","author":"Marzese","year":"2014","journal-title":"Neurooncol"},{"key":"10.1016\/j.jid.2017.03.039_bib24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2217\/epi.15.77","article-title":"Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives","volume":"7","author":"Marzese","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.jid.2017.03.039_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/med.21404","article-title":"Metastatic melanoma: insights into the evolution of the treatments and future challenges","volume":"37","author":"Millet","year":"2016","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jid.2017.03.039_bib26","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","article-title":"A\u00a0pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes","volume":"126","author":"Miranda","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jid.2017.03.039_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1756-0500-3-219","article-title":"Role of DNA methylation in miR-200c\/141 cluster silencing in invasive breast cancer cells","volume":"3","author":"Neves","year":"2010","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jid.2017.03.039_bib28","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.18632\/oncotarget.3142","article-title":"A\u00a0direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients","volume":"6","author":"Ono","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2017.03.039_bib29","doi-asserted-by":"crossref","first-page":"959461","DOI":"10.1155\/2014\/959461","article-title":"MicroRNAs: novel players in cancer diagnosis and therapies","volume":"2014","author":"Oom","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jid.2017.03.039_bib30","doi-asserted-by":"crossref","first-page":"W169","DOI":"10.1093\/nar\/gkt393","article-title":"DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows","volume":"41","author":"Paraskevopoulou","year":"2013","journal-title":"Nucleic Acid Res"},{"issue":"3","key":"10.1016\/j.jid.2017.03.039_bib31","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/gb-2011-12-3-r22","article-title":"Improving RNA-Seq expression estimates by correcting for fragment bias","volume":"12","author":"Roberts","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2017.03.039_bib32","doi-asserted-by":"crossref","first-page":"D56","DOI":"10.1093\/nar\/gks1172","article-title":"ENCODE data in the UCSC Genome Browser: year 5 update","volume":"41","author":"Rosenbloom","year":"2013","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/j.jid.2017.03.039_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.phrs.2016.03.012","article-title":"Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs","volume":"107","author":"Roskoski","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jid.2017.03.039_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1158\/2159-8290.CD-15-0893","article-title":"miRNA deregulation in cancer cells and the tumor microenvironment","volume":"6","author":"Rupaimoole","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2017.03.039_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0076-6879(06)11009-5","article-title":"TM4 microarray software suite","volume":"411","author":"Saeed","year":"2006","journal-title":"Method Enzymol"},{"key":"10.1016\/j.jid.2017.03.039_bib36","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1158\/1078-0432.CCR-13-0259","article-title":"The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma","volume":"19","author":"Sheppard","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2017.03.039_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jb\/mvi050","article-title":"Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in\u00a0vitro","volume":"137","author":"Takaki","year":"2005","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.jid.2017.03.039_bib38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Tan","year":"2014","journal-title":"EMBO Molec Med"},{"key":"10.1016\/j.jid.2017.03.039_bib39","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa1505270","article-title":"Palbociclib in hormone-receptor-positive advanced breast cancer","volume":"373","author":"Turner","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jid.2017.03.039_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jid.2017.03.039_bib41","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/ijc.25461","article-title":"Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer","volume":"128","author":"Wiklund","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2017.03.039_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12094-015-1364-1","article-title":"Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis","volume":"18","author":"Xu","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jid.2017.03.039_bib43","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.2011.568","article-title":"Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors","volume":"106","author":"Xu","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2017.03.039_bib44","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/pcmr.12228","article-title":"Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4\/6 inhibitor PD0332991 in melanoma cell lines","volume":"27","author":"Young","year":"2014","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17315282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17315282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T16:45:20Z","timestamp":1659026720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17315282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022202X17315282"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.03.039","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-200a Regulates CDK4\/6 Inhibitor Effect by Targeting CDK6 in Metastatic\u00a0Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}